Examining the temporality of vitamin E acetate in illicit THC-containing e-cigarette, or vaping, products from a public health and law enforcement response to EVALI — Utah, 2018-2020

Melissa M. Arons, Stephen R. Barnes, Rita Cheng, Kelly Whittle, Christopher Elsholz,David Bui,Stephen Gilley,Alejandra Maldonado,Nathan LaCross,Kylie Sage,Nathaniel Lewis,Keegan McCaffrey,Jordan Green,Janae Duncan,Angela C. Dunn

International Journal of Drug Policy(2021)

引用 6|浏览6
暂无评分
摘要
Background In the summer of 2019, e-cigarette, or vaping, product use-associated lung injury (EVALI) was detected in the United States. Multiple agencies reported illicit tetrahydrocannabinol (THC)-containing e-cigarette, or vaping, products containing vitamin E acetate (VEA) as a substance of concern. Methods As an expansion of the Utah Department of Health's response to EVALI, the Utah Public Health Laboratory and the Utah Department of Public Safety screened 170 products from 96 seizures between October 2018 and January 2020. Using Pearson's correlation coefficient, we analyzed the temporal correlation of national, and Utah specific case counts, and the percentage of seizures indicating VEA by month. Results The findings indicate strong and significant correlations between seizures indicating VEA and both the national (r = 0.70, p = 0.002) and Utah specific (r = 0.78, p < 0.001) case counts. Conclusion These findings underscore that VEA should not be added to e-cigarettes, or vaping, products and the importance of collaboration with law enforcement when responding to outbreaks associated with illicit substances.
更多
查看译文
关键词
EVALI,Vitamin E acetate,Public health,Law enforcement
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要